Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Uusimaa
P
P
Department of Internal Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland. paavo.uusimaa@oulu.fi
Tokola
H
H
Ruskoaho
H
H
Vuolteenaho
O
O
Risteli
J
J
Ylitalo
A
A
Peuhkurinen
K
K
D017311:Amlodipine / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000097:blood; D001539:Bendroflumethiazide / Q000627:therapeutic use; D006332:Cardiomegaly / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D019332:Endothelin-1 / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain; D020913:Perindopril / Q000627:therapeutic use; D011347:Procollagen / Q000097:blood; D016032:Randomized Controlled Trials as Topic
D000959:Antihypertensive Agents; D019332:Endothelin-1; D011347:Procollagen; D020097:Natriuretic Peptide, Brain; D017311:Amlodipine; D001262:Atenolol; D001539:Bendroflumethiazide; D009320:Atrial Natriuretic Factor; D020913:Perindopril